Health care stocks were declining late Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both fractionally lower.
The iShares Biotechnology ETF (IBB) rose 0.4%.
In corporate news, Pfizer (PFE) is collaborating with Atavistik Bio to accelerate the discovery of new precision allosteric therapeutics, Atavistik said. Pfizer shares added 0.5%.
BioNexus Gene Lab (BGLC) shares soared 45%. The company said that it was granted temporary exception until May 1 to regain compliance with Nasdaq's minimum bid price rule.
NRX Pharmaceuticals (NRXP) shares surged 35%. The company's Hope Therapeutics unit plans to acquire the Kadima Neuropsychiatry Institute.
Neumora Therapeutics (NMRA) shares plunged past 81% after a phase 3 trial of navacaprant to treat major depressive disorder failed to meet the primary endpoint.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。